Skip to main content
. Author manuscript; available in PMC: 2015 Apr 9.
Published in final edited form as: PM R. 2014 Sep 10;7(2):113–122. doi: 10.1016/j.pmrj.2014.09.003

Table 3.

Medications that may indicate the need for a pre-exercise evaluation before engaging in unsupervised moderate- or vigorous-intensity exercise

Medications Yes No Ratio (yes/no)a Pb
  High-Dose Steroids 26 (55%) 21 (45%) 1.2 .468
  Immunosuppressive Therapy 17 (36%) 30 (64%) 0.6 .068
  Aromatase Inhibitor 10 (22%) 37 (78%) 0.3 <.001
  Cardiac Agent 34 (72%) 13 (28%) 2.6 .005
  Pulmonary Agents 20 (43%) 27 (57%) 0.7 .312
  Anti-diabetic Agents 13 (28%) 34 (72%) 0.4 .005
  Appetite Suppressant 10 (21%) 37 (79%) 0.3 <.001
a

Ratios of 1, <1, and >1 indicate equivalence, majority exclusion, and majority inclusion of a characteristic as part of a pre-exercise screening, respectively.

b

Binomial P-value comparing the proportion who answered yes to the proportion who answered no.